BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2022 9:45:22 AM | Browse: 405 | Download: 938
|
Received |
|
2022-05-18 09:12 |
|
Peer-Review Started |
|
2022-05-18 09:15 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-06-23 16:07 |
|
Revised |
|
2022-07-07 02:59 |
|
Second Decision |
|
2022-09-02 03:27 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-09-07 23:51 |
|
Articles in Press |
|
2022-09-07 23:51 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-22 00:32 |
|
Publish the Manuscript Online |
|
2022-09-23 09:45 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cell Biology |
Manuscript Type |
Review |
Article Title |
Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Meng-Yue Shi, Lian Liu and Fu-Yuan Yang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Science and Technology Research Project of Hubei Province |
2021CFB210 |
|
Corresponding Author |
Fu-Yuan Yang, PhD, Lecturer, Health Science Center, Yangtze University, No. 1 Xueyuan Road, Jingzhou 434020, Hubei Province, China. ivansblue@sina.com |
Key Words |
Mesenchymal stem cells; Inflammatory bowel diseases; Inflammation; Pretreatment; Gene editing |
Core Tip |
Mesenchymal stem cell (MSC) transplantation is a novel treatment method for inflammatory bowel disease (IBD) that has exhibits certain achievements in clinical trials. Here, we reviewed the developed strategies for enhancing the therapeutic effect of MSCs, and among these, pretreatment with MSCs is the most common method. The pretreatments include bioactive substances, hypoxia and modification of culture methods and are able to enhance the migration ability of MSCs to repair the damaged intestinal mucosa or upregulate the expression of cytokines. These methods provide new ideas for the future clinical application of MSCs in the treatment of IBD. |
Publish Date |
2022-09-23 09:45 |
Citation |
Shi MY, Liu L, Yang FY. Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease. World J Stem Cells 2022; 14(9): 684-699 |
URL |
https://www.wjgnet.com/1948-0210/full/v14/i9/684.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v14.i9.684 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345